Comparison of Electroacupuncture and Mild-Warm Moxibustion on Brain-Gut Function in Patients with Constipation-Predominant Irritable Bowel Syndrome: A Randomized Controlled Trial

被引:30
|
作者
Zhao Ji-meng [1 ]
Lu Jin-hua [2 ]
Yin Xiao-jun [1 ]
Wu Lu-yi [1 ]
Bao Chun-hui [1 ]
Chen Xing-kui [3 ]
Chen Yue-hua [4 ]
Tang Wei-jun [5 ]
Jin Xiao-ming [6 ]
Wu Huan-gan [1 ]
Shi Yin [1 ]
机构
[1] Shanghai Univ Tradit Chinese Med, Shanghai Res Inst Acupuncture Moxibust & Meridian, Shanghai 200030, Peoples R China
[2] Jinhua Municipal Cent Hosp, Med Imaging Dept, Jinhua 321000, Zhejiang, Peoples R China
[3] Jinhua Municipal Cent Hosp, Dept Acupuncture & Moxibust, Jinhua 321000, Zhejiang, Peoples R China
[4] Jinhua Municipal Cent Hosp, Dept Digest Syst, Jinhua 321000, Zhejiang, Peoples R China
[5] Fudan Univ, Huashan Hosp, Radiol Dept, Shanghai 200040, Peoples R China
[6] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA
基金
中国国家自然科学基金;
关键词
irritable bowel syndrome; constipation; electroacupuncture; moxibustion; randomized controlled trial; VISCERAL HYPERSENSITIVITY; HEALTHY-VOLUNTEERS; FMRI; DISORDERS; RESPONSES; STIMULI; SCALE; PAIN; IBS; METAANALYSIS;
D O I
10.1007/s11655-018-2838-0
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Objective: To compare the effects of electroacupuncture (EA) and mild-warm moxibustion (Mox) therapies for constipation-predominant irritable bowel syndrome (C-IBS) patients. Methods: Sixty C-IBS patients were assigned to 2 groups by simple randomized method, i.e. EA group (30 cases) and Mox group (30 cases). Both EA and Mox treatments were performed on bilateral Tianshu (ST 25) and Shangjuxu (ST 37) for 30 min each time, 6 times per week, for 4 consecutive weeks. The gastrointestinal symptoms and psychological symptoms of the two groups were scored before and after treatment. The effects on the corresponding functional brain areas, namely the anterior cingulate cortex (ACC), insular cortex (IC) and prefrontal cortex (PFC) were observed by functional magnetic resonance imaging (fMRI) before and after treatment. Results: Compared with the Mox group, greater improvements in abdominal distension, defecation frequency, difficulty in defecation and stool features were observed in the EA group (all P < 0.01), both Hamilton Anxiety Rating Scale and Hamilton Depression Rating Scale scores were significantly decreased in the EA group (all P < 0.01). Finally, decreased activated voxel values were observed in the ACC, right IC and PFC brain regions of EA group with 150 mL colorectal distension stimulation (P < 0.05 or P < 0.01). Conclusions: Both EA and Mox could significantly improve some of the most intrusive symptoms of C-IBS patients, and EA was more effective than Mox. The therapeutic effect of these two therapies might through modulating of the brain-gut axis function.
引用
收藏
页码:328 / 335
页数:8
相关论文
共 42 条
  • [21] Effect of electroacupuncture at homotopic and heterotopic acupoints on abdominal pain in patients with irritable bowel syndrome: study protocol for a randomized controlled trial
    Yanhui Peng
    Hui You
    Xiaoman Chen
    Yanbing Chen
    Yiling Yang
    Jianpeng Huang
    Nenggui Xu
    Jianhua Liu
    Trials, 19
  • [22] Effect of electroacupuncture at homotopic and heterotopic acupoints on abdominal pain in patients with irritable bowel syndrome: study protocol for a randomized controlled trial
    Peng, Yanhui
    You, Hui
    Chen, Xiaoman
    Chen, Yanbing
    Yang, Yiling
    Huang, Jianpeng
    Xu, Nenggui
    Liu, Jianhua
    TRIALS, 2018, 19
  • [23] Randomized double blind placebo-controlled trial of Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: improvement in abdominal pain and bloating in those with predominant constipation
    Spiller, Robin
    Pelerin, Fanny
    Decherf, Amelie Cayzeele
    Maudet, Corinne
    Housez, Beatrice
    Cazaubiel, Murielle
    Justen, Peter
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2016, 4 (03) : 353 - 362
  • [24] The Effect of Phloroglucinol in Patients With Diarrhea-predominant Irritable Bowel Syndrome: A Randomized, Double-blind, Placebo-controlled Trial
    Shin, Seung Yong
    Cha, Bong Ki
    Kim, Won-Seok
    Park, Jae Yong
    Kim, Jeong Wook
    Choi, Chang Hwan
    JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, 2020, 26 (01) : 117 - 127
  • [25] Gut Microbiota is Not Modified by Randomized, Double-Blind, Placebo-Controlled Trial of VSL#3 in Diarrhea-Predominant Irritable Bowel Syndrome
    Michail, Sonia
    Kenche, Harshavardhan
    PROBIOTICS AND ANTIMICROBIAL PROTEINS, 2011, 3 (01) : 1 - 7
  • [26] Long-Term Success of GUT-Directed Group Hypnosis for Patients With Refractory Irritable Bowel Syndrome: A Randomized Controlled Trial
    Moser, Gabriele
    Traegner, Silja
    Gajowniczek, Ewelina Elwira
    Mikulits, Andrea
    Michalski, Maria
    Kazemi-Shirazi, Lili
    Kulnigg-Dabsch, Stefanie
    Fuehrer, Martina
    Ponocny-Seliger, Elisabeth
    Dejaco, Clemens
    Miehsler, Wolfgang
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 (04): : 602 - 609
  • [27] An invited commentary on "The efficacy and safety of probiotics for patients with constipation-predominant irritable bowel syndrome: A systematic review and meta-analysis based on seventeen randomized controlled trials" [Int. J. Surg. 79 (2020) 111-119]
    Petroianu, Andy
    INTERNATIONAL JOURNAL OF SURGERY, 2020, 80 : 3 - 4
  • [28] The Effects of Agave Fructans in a Functional Food Consumed by Patients with Irritable Bowel Syndrome with Constipation: A Randomized, Double-Blind, Placebo-Controlled Trial
    Camacho-Diaz, Brenda Hildeliza
    Arenas-Ocampo, Martha Lucia
    Osorio-Diaz, Perla
    Jimenez-Aparicio, Antonio Ruperto
    Alvarado-Jasso, Guadalupe Monserrat
    Saavedra-Briones, Eden Valfre
    Valdovinos-Diaz, Miguel angel
    Gomez-Reyes, Elisa
    NUTRIENTS, 2023, 15 (16)
  • [29] Gut Microbiota is Not Modified by Randomized, Double-Blind, Placebo-Controlled Trial of VSL#3 in Diarrhea-Predominant Irritable Bowel Syndrome
    Sonia Michail
    Harshavardhan Kenche
    Probiotics and Antimicrobial Proteins, 2011, 3 : 1 - 7
  • [30] Effects of a traditional herbal formula containing Melissa officinalis, Pimpinella anisum , and Rosa damascena on anxiety and depression in patients with constipation-predominant irritable bowel syndrome (IBS-C): A double-blind randomized clinical trial
    Azimi, Maryam
    Shahrbabaki, Hossein Karimi Dokht
    Raeiszadeh, Mahboobeh
    Eslami, Omid
    EXPLORE-THE JOURNAL OF SCIENCE AND HEALING, 2024, 20 (06)